Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHAPE2: BH4 and Vascular Function in Women
NCT02042196Phase 1Completed
- Sponsor
- University of Colorado Denver
- Start
- Dec 2013
- Primary completion
- May 2016
- Modality
- Allosteric Modulators, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of sapropterin in endothelial dysfunction (3 arms), sponsored by University of Colorado Denver. Primary endpoint: Change in brachial artery flow-mediated dilation. Started Dec 2013; status: completed.
02
Drugs
sapropterin
03
Conditions
endothelial dysfunction
Beyond the preview
Go deeper on NCT02042196.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02042196.